Market by Phase Type, Service, Sponsor, and Country Outlook | Forecast 2022-2028
A study by Triton Market Research on the European clinical trials support services market shows that it would develop with a CAGR of 8.15% in the forecast duration from 2022 to 2028.
Report scope can be customized per your requirements. Request For Customization
The countries analyzed in this market include:
• Italy
• The
United Kingdom
• Spain
• Germany
• France
• Rest
of Europe
Germany accounted for the
largest revenue share in 2021, making it the leading market in Europe.
The most critical part of clinical trial processes is the high-quality data gathered
by expert investigators. Europe boasts of skilled investigators offering
expertise, which makes it a key region for the clinical trials support services
market growth.
However,
the administrative burden in the region is significantly high, due to the
shortage of such skilled research personnel for executing the trial process.
This poses a major challenge to the growth of the market.
In
recent times, Italy has emerged as a key location for conducting important clinical
trial programs that are mostly focused on medicines, skills, knowledge, and
economic benefits. The Italian population takes a keen interest in participating
in these trials, and the onset of COVID-19 contributed largely in shaping this
public interest. It helped provide a better understanding of the impact and
value of medical innovation & biotechnology, especially new & advanced
therapeutic medicinal products.
With
the growing focus on research and development, the number of clinical trials
performed is increasing in the United Kingdom, and specifically in England. The
growing number of clinical trials also correlates to increased patient
recruitment.
In
2020, the top therapy areas for industry-sponsored clinical trials in the United
Kingdom were oncology (31.3% share), infectious diseases (18.2% share),
respiratory diseases (10.7% share), and central nervous system disorders (9.8%
share), and metabolic disorders (6.4% share). These developments indicate
an overall positive outlook for the UK market.
Clinical
trials of new drugs are an essential part of pharmaceutical and medical
research. However, it becomes difficult to execute these researches due to their
complexity and high costs involved. Thus, clinical trials are sponsored by different,
which makes it easy to conduct the trial process. Pharmaceutical and
biopharmaceutical companies are some of the key sponsors of clinical trials.
Triton’s report assesses the market
based on sponsor, phase type, and service. Here,
the sponsor segment comprises pharmaceutical & biopharmaceutical companies,
medical device companies, and other sponsors.
Noteworthy contenders in the clinical
trials support services market include ICON Plc, Charles River Laboratories,
Alcura, Parexel, KCR, WuXi AppTec, Worldwide Clinical Trials, and Syneos
Health.
KCR
is a contract research organization that offers solutions to biotechnology and
pharmaceutical organizations. It offers solutions for trial execution, consulting,
and placement. The organization’s placement services include data management,
e-documentation management, PV operations, and clinical operations. KCR was
founded in 1997 and is headquartered in Warsaw, Poland.
Key deliverables of the report:
· Market CAGR during the forecasting years 2022-2028
· Detailed data highlighting key insights, industry components, and market strategies
· Comprehensive information and estimation of the clinical trials support services market revenue growth in Europe and its influence on the parent market
· In-depth study of forthcoming trends in consumer behavioral patterns
· A meticulous analysis of the competitive landscape, vendor scorecard, and Porter’s Five Forces Model
·
A wide-ranging study of factors that will challenge the Europe clinical
trials support services market’s growth during the upcoming years
Want to get specific insights? Our team of analysts can customize
this report based on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET –
SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE CLINICAL TRIALS SUPPORT SERVICES MARKET
2.2. KEY
INSIGHTS
2.2.1. KEY
PLAYERS’ PROMISING COLLABORATIONS
2.2.2. INCREASE
IN SCREENING TESTS
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. KEY
BUYING IMPACT ANALYSIS
2.4.1. PERFORMANCE
2.4.2. EASE
OF USE
2.4.3. SECURITY
2.4.4. COST
EFFECTIVENESS
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. INDUSTRY
COMPONENTS
2.8. REGULATORY
FRAMEWORK
2.9. KEY
MARKET STRATEGIES
2.9.1. ACQUISITIONS
2.9.2. PRODUCT
LAUNCHES
2.9.3. CONTRACTS
& AGREEMENTS
2.9.4. INVESTMENTS
& EXPANSIONS
2.10. MARKET
DRIVERS
2.10.1. NEED
TO OVERCOME THE BARRIERS IN CLINICAL TRIALS
2.10.2. RISE
IN TRIALS DUE TO INCREASED DISEASE INCIDENCE
2.11. MARKET
CHALLENGES
2.11.1. DELAYED
APPROVAL DUE TO STRINGENT REGULATORY FRAMEWORK
2.11.2. USE OF
OPEN-SOURCE SOFTWARE
2.12. MARKET
OPPORTUNITIES
2.12.1. INCREASING
DEMAND FOR VACCINES AND PHARMACEUTICALS
2.12.2. DATA
MANAGEMENT SERVICE EXPECTED TO WITNESS NOTABLE GROWTH
2.12.3. ACQUISITIONS
IN THE CLINICAL TRIALS SUPPORT SERVICES MARKET
3. EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET
OUTLOOK – BY PHASE TYPE
3.1. PHASE
I
3.2. PHASE
II
3.3. PHASE
III
3.4. PHASE
IV
4. EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET
OUTLOOK – BY SERVICE
4.1. CLINICAL
TRIAL SITE MANAGEMENT
4.2. ADMINISTRATIVE
SERVICES
4.3. PATIENT
RECRUITMENT MANAGEMENT
4.4. REGULATORY
SERVICES
4.5. DATA
MANAGEMENT
4.6. OTHER
SERVICES
5. EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET
OUTLOOK – BY SPONSOR
5.1. PHARMACEUTICAL
& BIOPHARMACEUTICAL COMPANIES
5.2. MEDICAL
DEVICE COMPANIES
5.3. OTHER
SPONSORS
6. EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET –
COUNTRY OUTLOOK
6.1. UNITED
KINGDOM
6.2. GERMANY
6.3. FRANCE
6.4. SPAIN
6.5. ITALY
6.6. REST
OF EUROPE
7. COMPETITIVE
LANDSCAPE
7.1. IQVIA
7.2. PAREXEL
7.3. ICON
PLC
7.4. SYNEOS
HEALTH
7.5. LABCORP
DRUG DEVELOPMENT
7.6. CLINIPACE
7.7. KCR
7.8. CHARLES
RIVER LABORATORIES
7.9. MEDPACE
7.10. ALCURA
7.11. PSI
CRO
7.12. WORLDWIDE
CLINICAL TRIALS
7.13. CTI
CLINICAL TRIAL AND CONSULTING SERVICES INC
7.14. WUXI
APPTEC
7.15. ADVANCED
CLINICAL
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1: EUROPE CLINICAL
TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
TABLE 2: LIST OF
COLLABORATIONS
TABLE 3: VENDOR SCORECARD
TABLE 4: REGULATORY FRAMEWORK
TABLE 5: LIST OF ACQUISITIONS
TABLE 6: LIST OF PRODUCT
LAUNCHES
TABLE 7: LIST OF CONTRACTS
& AGREEMENTS
TABLE 8: LIST OF INVESTMENTS
& BUSINESS EXPANSIONS
TABLE 9: LIST OF PANDEMIC
OUTBREAKS
TABLE 10: LIST OF OPEN-SOURCE
SOFTWARE
TABLE 11: LAUNCH OF MEDICAL
DRUGS
TABLE 12: PROMISING
ACQUISITIONS IN THE MARKET
TABLE 13: EUROPE CLINICAL
TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $ MILLION)
TABLE 14: EUROPE CLINICAL
TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $ MILLION)
TABLE 15: EUROPE CLINICAL
TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $ MILLION)
TABLE 16: EUROPE CLINICAL
TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)
FIGURE
1: KEY BUYING IMPACT ANALYSIS
FIGURE
2: MARKET ATTRACTIVENESS INDEX
FIGURE
3: INDUSTRY COMPONENTS
FIGURE
4: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2021 &
2028 (IN %)
FIGURE
5: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE I, 2022-2028 (IN $
MILLION)
FIGURE
6: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE II, 2022-2028 (IN $
MILLION)
FIGURE
7: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE III, 2022-2028 (IN
$ MILLION)
FIGURE
8: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE IV, 2022-2028 (IN $
MILLION)
FIGURE
9: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2021 & 2028
(IN %)
FIGURE
10: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY CLINICAL TRIAL SITE
MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE
11: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY ADMINISTRATIVE SERVICES,
2022-2028 (IN $ MILLION)
FIGURE
12: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT
MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE
13: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY REGULATORY SERVICES,
2022-2028 (IN $ MILLION)
FIGURE
14: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY DATA MANAGEMENT,
2022-2028 (IN $ MILLION)
FIGURE
15: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SERVICES,
2022-2028 (IN $ MILLION)
FIGURE
16: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2021 & 2028
(IN %)
FIGURE
17: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHARMACEUTICAL &
BIOPHARMACEUTICAL COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE
18: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY MEDICAL DEVICE
COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE
19: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SPONSORS,
2022-2028 (IN $ MILLION)
FIGURE
20: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 &
2028 (IN %)
FIGURE
21: UNITED KINGDOM CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $
MILLION)
FIGURE
22: GERMANY CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
23: FRANCE CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
24: SPAIN CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
25: ITALY CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
26: REST OF EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $
MILLION)